Delivery Order SPE2DB20D3101-SPE2DB25FQYP4

Award Date 1/8/25
Potential Completion Date 1/9/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order (SPE2DB20D3104|SPE2DB24FV9B7) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $1,241.49, is for the delivery of ATOMOXETINE HCL 60 MG CAPSULE 30S, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for AmerisourceBergen to provide a...
The U.S. Department of Defense's (DoD) Defense Logistics Agency (DLA) Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of pharmaceutical products, including the supply of 4565140856 ATOMOXETINE HCL 40 MG CAPSULE 30S. The contract, with a ceiling value of $3,577.19, has an ultimate completion date of July 16, 2024 and was awarded on July 15, 2024. This order is part of a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of ATOMOXETINE HCL 10 MG CAPSULE 30S, a pharmaceutical product, to support military treatment programs and facilities. The contract has a firm fixed price, with a ceiling value of $1,208.48 and a period of performance through April 1, 2024. No set-aside designations were used for this contract. In addition...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,723.67 award is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, a pharmaceutical product, with a completion date of February 12, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite...
This is a delivery order contract awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,000.60 firm fixed-price contract is for the supply of 4,565,670,077 units of Atomoxetine HCL 40 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a completion date of September 5, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,600.04 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide ATOMOXETINE HCL 25 MG CAPSULE 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,315.00 firm fixed-price delivery order is for the supply of ATOMOXETINE HCL 18 30S, a pharmaceutical product. The contract has an ultimate completion date of November 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, with a potential value of $1,264.71 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp, operating out of its Corporate Office division in...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,400.42 firm fixed-price contract is for the supply of 4,565,699 units of Atomoxetine HCL 80 mg capsules to support federal healthcare programs. This order is a part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for delivering a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,432.16 firm fixed-price delivery order is for the supply of 4556432935 ATOMOXETINE HCL 40 MG CAPSULE 30S. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FQYP4
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $1,086.12, is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, a specialty medication. The contract has a firm fixed price pricing type and a completion date of January 9, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/9/25, 9:50 AM